Rigel Pharmaceuticals, Inc. (RIGL)

40.78 -1.27 (-3.02%) USD  |  NASDAQ  |  Dec 12, 16:00
41.50 +0.72 (+1.77%) After-Hours: 20:00
More

Rigel Pharmaceuticals Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for RIGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Nektar Therapeutics Upgrade
Vertex Pharmaceuticals, Inc. Upgrade